Edison Pharmaceuticals (United States)
- World rank, all time
- #29,846 of 42,892
- Rank in United States
- #6,390 of 8,685
- Research works
- 121 ▼ 60% vs 2013–17
- Citations
- 4.1k 34.1 per fractional work
- Top-10% rate
- 8.2% record average 16.5%
- Open access
- 42% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Computer Science, 3.9×. Every wedge is a field page.
- Computer Science 3.9×
- Decision Sciences 3.4×
- Neuroscience 2.7×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Immunology and Microbiology 2.2×
- Pharmacology, Toxicology and Pharmaceutics 2.1×
- Mathematics 1.9×
- Dentistry 1.5×
- Materials Science 1.2×
- Nursing 1.1×
- Chemistry 1.1×
- Medicine 1.0×
- Environmental Science 0.8×
- Health Professions 0.6×
- Engineering 0.5×
- Psychology 0.2×
- Social Sciences 0.2×
- Business, Management and Accounting 0.1×
Which keywords describe research at Edison Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Inflammation, Breast Cancer, Nanomedicine, Genetics, Inhaler Devices, Pulmonary Drug Delivery and Transcriptional Regulation.
- Status Epilepticus
- Therapeutic Antibodies
- Neurodegenerative Diseases
- Monoclonal Antibodies
- Toxicology
- Estrogen
- Antiepileptic Drugs
- Medicinal Chemistry
- Reactive Oxygen Species
- Signaling
- Mitochondrial Dysfunction
- Migraine
- Calcitonin Gene-Related Peptide
- Catalysis
- Transcriptional Regulation
- Inhaler Devices
- Nanomedicine
- Genetics
- Oxidative Stress
- Nanoparticles
- Inflammation
- Epidemiology
- Treatment
- Breast Cancer
- Neurological Disorders
- Pulmonary Drug Delivery
- Chemotherapy
- Circadian Rhythms
- Headache Disorders
- Glycosylation
- Rheology
- Neurobiology
- G Protein-Coupled Receptor
- Nuclear Receptors
- Antimicrobial Resistance
- Receptor
- Epilepsy
- Monoclonal Antibody
- Seizures
- Sleep
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation8▲ 2.8×30 topics
- Nanoparticles8▲ 4.9×8 topics
- Epidemiology7▲ 1.42×19 topics
- Oxidative Stress6▲ 2.7×19 topics
- Treatment6▲ 3.5×11 topics
- Genetics5▲ 5.4×7 topics
- Breast Cancer4▲ 13×3 topics
- Nanomedicine4▲ 40×2 topics
- Neurological Disorders4▲ 5.2×5 topics
- Inhaler Devices4▲ 113×1 topic
- Pulmonary Drug Delivery4▲ 113×1 topic
- Transcriptional Regulation4▲ 13×3 topics
- Chemotherapy3▲ 3.8×7 topics
- Catalysis3▲ 3.1×5 topics
- Circadian Rhythms3▲ 31×2 topics
- Calcitonin Gene-Related Peptide3▲ 29×2 topics
- Headache Disorders3▲ 94×1 topic
- Migraine3▲ 52×1 topic
- Glycosylation3▲ 10×3 topics
- Mitochondrial Dysfunction3▲ 6.2×7 topics
- Rheology3▲ 10×4 topics
- Signaling3▲ 20×3 topics
- Neurobiology3▲ 6.4×3 topics
- Reactive Oxygen Species3▲ 4.4×6 topics
- G Protein-Coupled Receptor2▲ 31×2 topics
- Medicinal Chemistry2▲ 5.5×3 topics
- Nuclear Receptors2▲ 11×2 topics
- Antiepileptic Drugs2▲ 20×2 topics
- Antimicrobial Resistance2▲ 7.8×3 topics
- Estrogen2▲ 26×1 topic
- Receptor2▲ 27×1 topic
- Toxicology2▲ 8.8×6 topics
- Epilepsy2▲ 14×2 topics
- Monoclonal Antibodies2▲ 11×2 topics
- Monoclonal Antibody2▲ 24×2 topics
- Neurodegenerative Diseases2▲ 7.5×3 topics
- Seizures2▲ 22×2 topics
- Therapeutic Antibodies2▲ 13×2 topics
- Sleep2▲ 38×1 topic
- Status Epilepticus2▲ 27×1 topic
Which research topics does Edison Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Matrix Theory and Algorithms, Signaling Pathways in Disease, Cloud Computing and Resource Management and Pancreatic function and diabetes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Matrix Theory and Algorithms Computational Theory and Mathematics 1 works
- 2 Signaling Pathways in Disease Molecular Biology 1 works
- 3 Cloud Computing and Resource Management Information Systems 0 works
- 4 Pancreatic function and diabetes Surgery 0 works
- 5 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
- 6 Software System Performance and Reliability Computer Networks and Communications 0 works
- 7 Protein Structure and Dynamics Molecular Biology 0 works
- 8 Robotic Process Automation Applications Industrial and Manufacturing Engineering 0 works
- 9 Speech Recognition and Synthesis Artificial Intelligence 0 works
- 10 Enzyme Structure and Function Materials Chemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Edison Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 60% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mountain View
- Ames Research Center
- Google (United States)
- Creative Commons
- Synopsys (United States)
- Search for Extraterrestrial Intelligence
- Khan Academy
- Intuit (United States)
- Research Institute for Advanced Computer Science
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.